Schizophrenia Trial, Recruiting (NCT05457140)

Schizophrenia Trial, Recruiting NCT05457140 Sponsor: Rady Pediatric Genomics & Systems Medicine Institute Condition: Schizophrenia

Printed from Voxsanity (voxsanity.com.au) — NCT05457140 — Data sourced from ClinicalTrials.gov. Verify directly with the trial site before attending. Not medical advice.

Back to Schizophrenia

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

You are a child or teenager who has been admitted to Rady Children's CAPS unit and is showing symptoms of psychosis for the first time.
You are a biological parent of a child or teenager already enrolled in this study (for the purpose of genetic comparison testing).

Who may not be able to join:

Children or teenagers who do not meet either of the criteria listed above.
Anyone who has already had whole genome sequencing or exome sequencing done (types of detailed genetic testing) before joining the study.
People who could not be approached or contacted to be asked about joining the study.
People who are unable to give informed consent (agreement to participate after being fully informed).
Family members who are known to not be biologically related to the child or teenager already in the study.
Family members who belong to a legally protected research population (confirm with trial site).

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.

Last synced 14 July 2026

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Aaron Besterman, MD, Rady Pediatric Genomics & Systems Medicine Institute

Phone: 858-576-1700

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Voxsanity

Clinical trials and treatments, explained plainly · voxsanity.com.au

Date:

To: My Doctor

Re: Clinical trial enquiry

I am writing to enquire about the following clinical trial which may be relevant to my care:

Trial: NCT05457140

Sponsor: Rady Pediatric Genomics & Systems Medicine Institute

Phase: Not Applicable

Status: Recruiting

Condition: Schizophrenia

Trial contact: 858-576-1700

More information: https://clinicaltrials.gov/study/NCT05457140

Eligibility summary (AI generated)

Written by an AI model from ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

Who might be able to join this trial:

You are a child or teenager who has been admitted to Rady Children's CAPS unit and is showing symptoms of psychosis for the first time.
You are a biological parent of a child or teenager already enrolled in this study (for the purpose of genetic comparison testing).

Who may not be able to join:

Children or teenagers who do not meet either of the criteria listed above.
Anyone who has already had whole genome sequencing or exome sequencing done (types of detailed genetic testing) before joining the study.
People who could not be approached or contacted to be asked about joining the study.
People who are unable to give informed consent (agreement to participate after being fully informed).
Family members who are known to not be biologically related to the child or teenager already in the study.
Family members who belong to a legally protected research population (confirm with trial site).

Important: Always verify eligibility with the trial site directly before applying.

Access in Australia: A treatment being studied in a clinical trial is generally not yet listed on the PBS. Where a medicine is not approved or not available through a trial, the TGA Special Access Scheme may allow a doctor to access unapproved therapeutic goods for individual patients. See voxsanity.com.au/sas-navigator/ for a plain English explainer.

This information was sourced from ClinicalTrials.gov via Voxsanity (data last synced 14 July 2026). It is not medical advice. Please verify the trial's current status directly with the trial site before acting.

Trial details

Status

Recruiting

Phase

Not Applicable

Sponsor

Rady Pediatric Genomics & Systems Medicine Institute

Registry

ClinicalTrials.gov

Start date

10 October 2022

Est. completion

1 August 2025

Where this trial is recruiting

🇺🇸 United States

Primary endpoints

Diagnostic rate of brain reactive autoantibodies

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 14 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov